Vestmark Advisory Solutions, Inc.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1736982
Wakefield, MA
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,473,562
-$699,150 QoQ
Shares Held
8,217
-14.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#301
of 780 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vestmark Advisory Solutions, Inc. holds $64,583,105 across 33 Biotechnology names. ALNY ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
242,266 | $13,213,187 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
532,817 | $9,015,263 | |
| 3 | BEAM |
Beam Therapeutics Inc.
|
164,164 | $5,634,108 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,762 | $3,855,617 | |
| 5 | TECH |
BIO-TECHNE Corp
|
44,928 | $3,174,163 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
708,858 | $2,601,507 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
8,217 | $2,473,562 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
6,681 | $2,236,731 |
All Filings in ALNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,473,562 | 8,217 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,172,712 | 9,589 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,490,571 | 8,778 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $494,760 | 1,085 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $567,396 | 1,740 | Shares | Other | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||